The FDA has approved fitusiran, now Qfitlia, as a treatment for hemophilia A or B patients, ages 12 and older, with or ...

Columnist Alliah Czarielle, who's experienced the ups and downs of her husband's hemophilia, savors time when nothing special is going on.

Alhemo prophylaxis is linked to better quality of life and a lower treatment burden for hemophilia patients without ...

Columnist G. Shellye Horowitz chats with Hannes Jung, creator of the Bleeder app, which helps hemophilia patients track ...

About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...

It’s that time of year again when brackets are busted, Cinderella stories happen, and basketball fans everywhere are glued to the television for the madness of March. The NCAA basketball tournament is ...

Due to hemophilia A patients switching to newer treatments, Takeda Pharmaceuticals is discontinuing both Hemofil M and ...

This year's Manila Pen Show felt extra special for columnist Alliah Czarielle and her family. It was a lesson on finding ...

A recent gathering of the New Mexico bleeding disorders community provided many opportunities for support, columnist Joe MacDonald says.

At an international conference, columnist G Shellye Horowitz has a bleed that spurs questions about how women with hemophilia ...